by in
Entry Author Date Location
FDA To Yank Avastin Breast Cancer Approval 12/16/10 San Francisco
Genomic Health Seeks to Build Momentum For Healthcare Shift from Rx to Dx 11/08/10 San Francisco
PacBio IPO, Not Exactly the Netscape Moment of 2010, But a Win for Genomics 10/28/10 San Francisco
Genentech’s Souped-Up Breast Cancer Drug Beats Original Herceptin in Head-to-Head Study 10/08/10 San Francisco
Cerulean Pharma Makes Progress in Attacking the Big C with Tiny Drugs 09/07/10 Boston
ImmunoGen and Genentech “Empowered Antibody” Cancer Drug Fails to Garner Accelerated Approval from FDA 08/27/10 Boston
Biocept Targets Spreading Tumors With Advance in Diagnostics 08/20/10 San Diego
Syndax Pharma Snags $6M Debt Deal 08/09/10 Boston
Genentech Fails to Sway FDA Panel 07/20/10 San Francisco
Corey Goodman’s New Startup, UCSF Spinoff Raises $40M, Gail Maderis Gives Back, & More Bay Area Life Sciences News 07/09/10 San Francisco
Genentech Seeks FDA Nod for T-DM1 07/07/10 San Francisco
On-Q-ity, Led by Former Genzyme Exec, Takes on “Diagnostic Black Hole” in Cancer 07/07/10 Boston
Tesaro: Former MedImmune CEO’s Firm Writes Check, Cancer Drug Vets Build Pipeline 06/28/10 Boston
Genentech’s Souped-Up Antibody, Reg Kelly’s Mission, LS9 Nears Moment of Truth & More Bay Area Life Sciences News 06/25/10 San Francisco
Genentech’s Souped-Up Herceptin: The Odyssey Toward a More Powerful Breast Cancer Drug 06/14/10 San Francisco
Biogen CEO Retires, Genzyme Board Nominates Amgen Vet and Strikes Deal with Icahn, Xconomy Spotlights Life Sciences XSITE Speakers, & More Boston-Area Life Sciences News 06/11/10 Boston
Syndax’s Breast Cancer Drug Advances, Arena Raises Equity Financing, BeneChill Recruits a CEO, & More San Diego Life Sciences News 06/10/10 San Diego
Syndax Pharma Seeks to Reprogram Tumor Cells to Treat Breast Cancer 06/08/10 Boston
All-Michigan VC Team Helps Bring State-Grown Medical Imaging Technology to Market 06/03/10 Detroit
Detroit Breast Cancer Imaging Company Delphinus Medical Gets $8M Investment 05/25/10 Detroit
Who Needs VCs? Steven Quay’s Atossa Genetics Seeks Fast IPO For Breast Cancer Test 05/21/10 Seattle
Aragon Pharmaceuticals Moves to First Clinical Trial with $22M 04/22/10 San Diego
Foundation Medicine Raises $25M to Get to the Bottom of Cancer Genomes 04/14/10 Boston
West Wireless Names CEO, Amylin Pharmaceuticals Awaits FDA Deadline, Life Technologies In Cancer Research Partnership, & More San Diego Life Sciences News 03/11/10 San Diego
Life Tech to Sequence Breast Cancer Genomes 03/05/10 San Diego
Roche Prepares to Make Devices for Drug Using Halozyme Therapeutics Technology 01/21/10 San Diego
Calixa Gets Acquired, Pfēnex signs Merck to Licensing Deal, Local Biotechs Report From Breast Cancer Symposium, & More San Diego Life Sciences News 12/17/09 San Diego
San Diego’s BioTheranostics Gears Up to Sell Test That Predicts Breast Cancer Relapse 12/12/09 San Diego
Breast Cancer “Smart Bomb” From Roche, ImmunoGen Shows Tumor Shrinkage in Big Test 12/09/09 Boston
Supercharged Herceptin Nears Pivot Point, as ImmunoGen, Roche Await Data on Breast Cancer “Smart Bomb” 12/07/09 Boston
Page 3 of 4 « previous page · next page »